RVX Share Price

Open 1.46 Change Price %
High 1.55 1 Day -0.06 -4.00
Low 1.40 1 Week 0.13 9.92
Close 1.44 1 Month 0.03 2.13
Volume 71146 1 Year 0.24 20.00
52 Week High 2.47
52 Week Low 1.12
RVX Important Levels
Resistance 2 1.58
Resistance 1 1.52
Pivot 1.46
Support 1 1.36
Support 2 1.30
TSE Canada Most Active Stocks
BIN 41.40 -1.62%
BIN 41.40 -1.62%
LSG 2.08 8.33%
LSG 2.08 8.33%
LSG 2.08 8.33%
TBE 0.03 0.00%
CVE 10.89 9.45%
CVE 10.89 9.45%
CVE 10.89 9.45%
G 16.07 -6.24%
More..
TSE Canada Top Gainers Stocks
CUR 0.02 100.00%
CUR 0.02 100.00%
CUR 0.02 100.00%
TVI 0.02 100.00%
PWC 0.10 25.00%
PWC 0.10 25.00%
ANX 0.06 20.00%
ANX 0.06 20.00%
CUM 0.90 13.92%
CUM 0.90 13.92%
More..
TSE Canada Top Losers Stocks
TPL 0.02 -33.33%
TPL 0.02 -33.33%
GBV 0.46 -24.59%
ME 0.14 -12.50%
ME 0.14 -12.50%
TNX 0.51 -10.53%
CTU-A 0.19 -9.52%
ONC 0.51 -8.93%
ONC 0.51 -8.93%
TLB 3.42 -7.07%
More..

Resverlogix Corp (TSE: RVX)

RVX Technical Analysis 5
As on 27th Jul 2017 RVX Share Price closed @ 1.44 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.83 & Strong Sell for SHORT-TERM with Stoploss of 1.64 we also expect STOCK to react on Following IMPORTANT LEVELS.
RVX Target for July
1st Target up-side 1.97
2nd Target up-side 2.34
3rd Target up-side 2.71
1st Target down-side 0.91
2nd Target down-side 0.54
3rd Target down-side 0.17
RVX Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.resverlogix.com
RVX Address
RVX
279 Midpark Way S.E.
Suite 202
Calgary, AB T2X 1M2
Canada
Phone: 403-254-9252
Fax: 403-256-8495
RVX Latest News
Stock Check: Viewing Levels For Resverlogix Corp (RVX.TO)   Rives Journal   - 27th Jul 17
Resverlogix Corp (RVXCF) AO Seeing a Consistent Trend Higher   Ozark Times   - 27th Jul 17
Resverlogix Corp (RVX.TO) Moves 2.56%   Evergreen Caller   - 26th Jul 17
Resverlogix Files 2017 Year-End Disclosure Documents and Announces Plans to ...   PR Newswire (press release)   - 26th Jul 17
Resverlogix Randomizes First Patient in Taiwan/China Portion of the Phase 3 ...   PR Newswire (press release)   - 10th Jul 17
Eastern Capital Limited Acquires Additional Shares and Warrants of Resverlogix ...   Canada NewsWire (press release)   - 21st Jun 17
Resverlogix: The Science Is Getting 'BETter' For RVX208   Seeking Alpha   - 27th Feb 17
Resverlogix Highlights Unique Properties of Apabetalone in Both a Rare ...   Canada NewsWire (press release)   - 13th Feb 17
Resverlogix: Analysis Of The Science Behind RVX-208   Seeking Alpha   - 08th Apr 15
1.2453   MarketWatch   - 21st Apr 11
Interactive Technical Analysis Chart Resverlogix Corp ( RVX TSE Canada )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Resverlogix Corp
RVX Business Profile
Resverlogix Corp., a clinical stage cardiovascular company, develops compounds, which include a therapeutic increase in Apolipoprotein A-I. It primarily develops RVX-208, a small molecule that has completed a Phase IIb clinical trial SUSTAIN and is undergoing a second Phase IIb trial ASSURE for the treatment of atherosclerosis and other chronic diseases, such as neurodegenerative disorders, diabetes mellitus, and Alzheimer's disease. The company is headquartered in Calgary, Canada.